Anzeige
Mehr »
Dienstag, 23.12.2025 - Börsentäglich über 12.000 News
Breaking News: Drohnenabwehr aus Israel für die NATO?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PUQT | ISIN: DK0061155009 | Ticker-Symbol:
1-Jahres-Chart
PHARMA EQUITY GROUP A/S Chart 1 Jahr
5-Tage-Chart
PHARMA EQUITY GROUP A/S 5-Tage-Chart

Aktuelle News zur PHARMA EQUITY GROUP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
10.12.Pharma Equity Group A/S: Pharma Equity Group executes on the Company's new strategy: Enters into Letter of Intent to acquire the MedTech company Otiom A/S74Pharma Equity Group executes on the Company's new strategy: Enters into Letter of Intent to acquire the MedTech company Otiom A/S Copenhagen, 10 December 2025 Company Announcement no. 15 Pharma Equity...
► Artikel lesen
03.12.Pharma Equity Group A/S' agreement with Danske Bank as liquidity provider will terminate on 1 January 2026156Pharma Equity Group A/S' agreement with Danske Bank as liquidity provider will terminate on 1 January 2026 3 December 2025 Company Announcement no. 14 Pharma Equity Group A/S ("PEG") announces that...
► Artikel lesen
01.12.Pharma Equity Group A/S: The Board of Directors' resolution on the issuance of convertible loans1
26.11.Pharma Equity Group A/S: Corrective information regarding the Annual Report 2024 and the Interim Report for H1 2025 following an order from the Danish Business Authority1
01.10.Pharma Equity Group A/S: The Board of Directors' resolution on the issuance of convertible loans1
01.09.Pharma Equity Group A/S: Pharma Equity Group's subsidiary, Reponex Pharmaceuticals A/S, receives regulatory approval to initiate pivotal clinical trial with RNX-011 for life-threatening peritonitis304Pharma Equity Group's subsidiary, Reponex Pharmaceuticals A/S, receives regulatory approval to initiate pivotal clinical trial with RNX-011 for life-threatening peritonitis Copenhagen, September...
► Artikel lesen
PHARMA EQUITY GROUP Aktie jetzt für 0€ handeln
14.08.Pharma Equity Group A/S: Consolidated Interim Report 1 January - 30 June 2025137Consolidated Interim Report 1 January - 30 June 2025Key points from the H1-2025 report (period 1 January - 30 June 2025) 14 August 2025Announcement no. 9 On 14 August 2025, the Board of Directors...
► Artikel lesen
01.07.Pharma Equity Group A/S: The Board of Directors' resolution on the issuance of convertible loans1
28.05.Pharma Equity Group A/S Launches New Strategy to Drive Growth and Shareholder Returns396Pharma Equity Group A/S Launches New Strategy to Drive Growth and Shareholder Returns 28 May 2025Announcement no. 7 Pharma Equity Group (PEG) today announces the launch of a transformative...
► Artikel lesen
05.05.Passing of the General Meeting of Pharma Equity Group A/S307Passing of the General Meeting of Pharma Equity Group A/S 5th of May 2025Company Announcement no. 6 The chairman of the meeting reviewed the agenda for today's general meeting, which was: The Board...
► Artikel lesen
20.03.Pharma Equity Group A/S - Annual Report 2024251Pharma Equity Group A/S - Annual Report 2024 Date: 20 March 2025 Announcement No. 2 Pharma Equity Group A/S - Annual Report 2024 - main features of the year The Board of Directors of Pharma Equity Group...
► Artikel lesen
11 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1